4//SEC Filing
Mehta Vimal 4
Accession 0001104659-25-002693
CIK 0001720893other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 8:03 PM ET
Size
5.6 KB
Accession
0001104659-25-002693
Insider Transaction Report
Form 4
Mehta Vimal
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2025-01-07+660,000→ 660,000 totalExercise: $0.47Exp: 2035-01-07→ Common Stock (660,000 underlying)
Footnotes (1)
- [F1]On January 7, 2025, the Reporting Person was granted an option to purchase 660,000 shares of common stock, which vests in twelve equal monthly installments over a twelve-month period following the grant date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001733369
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 8:03 PM ET
- Size
- 5.6 KB